Emalex Biosciences, Inc.

ACTIVE

330 N Wabash Ave Ste 3500, 伊利诺伊州库克县, 伊利诺伊州, United Stateswww.emalexbiosciences.comHolding11–50 employeesEstablished: 2018-01-01

Clinical Trials

6 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2018

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

57.7%

Phase 2

19.2%

Phase 3

19.2%

Trial Status Distribution

Active, not recruiting

23.1%

Available

3.9%

Completed

53.9%

Recruiting

11.5%

Terminated

7.7%

Clinical Trials

Trials sponsored by this organization (26)

Food-effect Study of Ecopipam Pharmacokinetics

Phase 1

Completed

interventional

Nov 202425 participants

Drug Interaction Study

Phase 1

Completed

interventional

Jan 202445 participants

A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder

Phase 3

Active, not recruiting

interventional

Aug 2023150 participants

ong Term Study of Ecopipam Tablets in Children, Adolescents and Adults with Tourette’s Disorder

Phase 1

Recruiting

interventional

Apr 2023141 participants

Thorough QT/QTc Study to Evaluate the Effects of Ecopipam (EBS-101) on Cardiac Repolarization

Phase 1

Completed

interventional

Mar 202329 participants

Ecopipam Tablets to Study Tourette’s Disorder in Children, Adolescents and Adults (D1AMOND)

Phase 1

Recruiting

interventional

Feb 2023239 participants

Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults

Phase 3

Completed

interventional

Jan 2023216 participants

Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates for Drug Metabolism and Transport

Phase 1

Completed

interventional

Apr 202256 participants

Page 1 of 4

Approvals

No approval data available

News

No news articles found

Back to Organizations